Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

ESC recommends patients and centres for renal denervation

Up to 10 per cent of patients with high blood pressure are resistant to treatment, which puts them at increased risk of cardiovascular events, including heart attacks. Clinical trials show that catheter-based renal denervation reduces blood pressure in patients who do not respond to conventional drug therapy.

Doctoring Amid Devices

Messy. That is how a bioengineer once described the environment within the human body to me. Many implantable medical devices are an achievement in ingenuity that overcomes “messiness” like biocompatibility, blood and torsion. But few are indestructible or 100 percent fail-safe.

HRS.13: Expanding Knowledge & Partnerships

Anne M. Gillis, MD, president of the Heart Rhythm Society 
and a professor at the University of Calgary, discussed highlights of Heart Rhythm 2013 that starts May 8 in Denver and how the scientific sessions continue to evolve.

A Left-handed Complement to PCI

Most operators prefer a right radial approach for PCI, but left radial access offers some advantages that have begun to win over converts.

Carotid Stenting: Where Science & Policy Diverge

A 68-year-old gentleman was recently referred to me by his cardiologist, who had heard a carotid bruit on a routine exam.

Vascular Surgery Training: Options & Opportunities

No longer requiring certification in general surgery prior to certification in vascular surgery created several training pathways.

Cook recalls Zilver PTX Drug Eluting Peripheral Stent

Cook Medical is recalling its Zilver PTX Drug Eluting Peripheral Stent after receiving complaints about delivery system tip separation. Two adverse events, including one death, occurred in cases where a tip separation was reported.

Development & Growth of TAVR in the U.S.

Since the FDA’s approval of transcatheter aortic valve replacement (TAVR) in 2011, improvements and scientific evidence have continued to mount.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.